|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 16,02 PLN | +6,09% |
|
+6,80% | -40,89% |
| 21/05 | Ryvu Therapeutics : perte nette de 12,6 millions de zlotys au premier trimestre | RE |
| 21/05 | Ryvu Therapeutics S.A. publie ses résultats pour le premier trimestre clos le 31 mars 2026 | CI |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +6,09% | +6,80% | +5,67% | -34,07% | -40,89% | -47,39% | -73,03% | -71,70% | -27,41% | 93,57 M | |
| +4,35% | +19,90% | +18,84% | +34,64% | +62,73% | +60,59% | +95,21% | -7,16% | - | 62,53 Md | |
| +2,83% | -3,03% | -9,89% | +9,38% | +4,44% | +27,40% | +67,25% | +183,02% | +5 707,60% | 52,43 Md | |
| +0,91% | -0,29% | -5,50% | -7,22% | -3,17% | -16,22% | -13,43% | -77,76% | - | 23,1 Md | |
| +0,27% | -4,91% | -11,27% | -29,28% | -43,11% | -10,99% | +350,30% | +299,76% | +742,01% | 21,4 Md | |
| +0,40% | +5,29% | +8,15% | +17,53% | +29,20% | +30,11% | -9,63% | -69,06% | - | 21,17 Md | |
| +0,75% | -0,84% | +1,26% | +10,81% | -6,66% | +33,80% | -25,25% | -35,43% | +54,07% | 17,76 Md | |
| +9,88% | +19,73% | +6,16% | +129,59% | +215,08% | +229,67% | +385,49% | +1 639,03% | +785,92% | 15,47 Md | |
| +2,08% | -3,28% | -1,44% | +6,68% | +25,40% | +21,67% | +564,59% | - | - | 14,68 Md | |
| +1,25% | +0,34% | +1,52% | +28,37% | +29,36% | +54,03% | +179,72% | +237,70% | +412,20% | 14,08 Md | |
| -2,99% | +1,32% | +3,48% | +13,77% | +30,91% | +427,85% | +174,60% | +31,44% | +1 373,05% | 12,62 Md | |
| +1,29% | -4,58% | -2,65% | -0,88% | -11,71% | +64,72% | +164,36% | +507,85% | +6 942,74% | 11,73 Md | |
| +1,76% | -0,52% | -6,74% | -25,27% | -15,49% | -37,21% | +161,64% | +91,19% | - | 11,02 Md | |
| -1,67% | +7,81% | -12,26% | -20,32% | -22,64% | -53,85% | +597,42% | +70,83% | +91,94% | 10,98 Md | |
| +0,31% | -0,76% | -8,83% | +19,38% | +24,10% | +115,55% | +137,57% | +167,20% | +564,84% | 10,67 Md | |
| -0,56% | +4,39% | +20,45% | +50,95% | +218,53% | +545,73% | +769,40% | -36,76% | -12,86% | 9,23 Md | |
| +0,17% | +0,17% | +98,91% | +103,64% | +80,45% | +197,66% | +349,20% | +378,36% | - | 8,89 Md | |
| +2,55% | -2,60% | -5,98% | -15,89% | +14,65% | +39,56% | +100,12% | -18,27% | - | 7,96 Md | |
| +2,25% | +2,42% | -4,23% | -4,39% | +21,20% | +65,84% | +12,61% | +143,66% | - | 7,9 Md | |
| -1,33% | +3,93% | +9,25% | +15,08% | +19,00% | +250,79% | +267,25% | +539,49% | - | 7,32 Md | |
| Moyenne | +1,53% | +2,20% | +5,24% | +15,13% | +31,57% | +99,97% | +212,77% | +209,13% | +1 512,19% | 17,05 Md | |
| Moyenne pondérée par Capi. | +1,98% | +3,57% | +3,95% | +17,99% | +32,29% | +77,22% | +175,31% | +178,48% | +2 491,92% |
- Bourse
- Actions
- Action RVU
- Secteur Ryvu Therapeutics S.A.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
